Amgen’s rally boosts biotech sector
March 11, 2011 at 13:31 PM EST
One analyst says the market is speculating that Medicare rates for one of Amgen’s top products will remain unchanged.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.